Profil
Jennifer Maggio worked as Director-Finance & Accounting at Accuray, Inc. from 2006 to 2011.
She then worked as Vice President & Controller at SI-BONE, Inc. She also worked as Controller at Ventus Medical, Inc. in 2012.
Recently, she worked as Vice President & Controller at Seer, Inc. (California) from 2020 to 2022.
Ms. Maggio completed her undergraduate degree from The California State University in 2000.
Anciens postes connus de Jennifer Maggio
| Sociétés | Poste | Fin |
|---|---|---|
| SEER, INC. | Comptroller/Controller/Auditor | 01/07/2022 |
Ventus Medical, Inc.
 Ventus Medical, Inc. Medical SpecialtiesHealth Technology Ventus Medical manufactured and distributed medical devices Located in Belmont, California, Ventus Medical has developed a new breakthrough therapy for obstructive sleep apnea (OSA). OSA afflicts roughly 50 million people in the United States alone, and existing solutions do not always meet patient's needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. Ventus Medical has conducted several randomized clinical studies across the United States and has received FDA clearance for PROVENT Sleep Apnea Therapy. | Comptroller/Controller/Auditor | 01/10/2012 |
| ACCURAY INCORPORATED | Directeur Financier/CFO | 01/12/2011 |
| SI-BONE, INC. | Comptroller/Controller/Auditor | - |
Formation de Jennifer Maggio
| The California State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SI-BONE, INC. | Health Technology |
| ACCURAY INCORPORATED | Health Technology |
| SEER, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ventus Medical, Inc.
Ventus Medical, Inc. Medical SpecialtiesHealth Technology Ventus Medical manufactured and distributed medical devices Located in Belmont, California, Ventus Medical has developed a new breakthrough therapy for obstructive sleep apnea (OSA). OSA afflicts roughly 50 million people in the United States alone, and existing solutions do not always meet patient's needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. Ventus Medical has conducted several randomized clinical studies across the United States and has received FDA clearance for PROVENT Sleep Apnea Therapy. | Health Technology |
